infliximab,certolizumab,golimumab,tofacitinib,guselkumab,adalimumab,etanercept,bimekizumab,upadacitinib,methotrexate,ustekinumab,ixekizumab,secukinumab
janssen,abbvie,ucb pharmaceuticals,eli lilly,amgen,novartis
['etanercept', 'ustekinumab', 'guselkumab', 'tofacitinib', 'adalimumab', ' psa', 'elevate,uc,12', 'ixekizumab', 'risan', 'upadacitinib', 'secukinumab', 'bimekizumab', 'elevate,uc,52', 'infliximab', 'methotrexate', 'tofa', 'golimumab', 'certolizumab']
eular recommendations: psa( peripheral arthritis domain): for jak use follow ema safety guidelines. #eular2022 
Rheumatologist and life long learner 🤓. Citizen of the world.Special shoutout to my students and patients, you got this💪🏽. 😷